← Back to Search

Procedure

DISC-MA for Depression and Anxiety (PAPI Trial)

N/A
Waitlist Available
Led By Tim Campellone, PhD
Research Sponsored by Woebot Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week and post-treatment at 4 weeks
Awards & highlights

PAPI Trial Summary

This trial aims to show how precision treatments can work in adults.

Who is the study for?
This trial is for adults aged 18-75 in the U.S. with mild or greater symptoms of depression and/or anxiety, who can read/write English, have a recent smartphone with Wi-Fi/data to engage in the study for 4 weeks.Check my eligibility
What is being tested?
The study tests DISC-MA, aiming to prove it can precisely treat depression and anxiety. Participants will use their smartphones to interact with this intervention over a month.See study design
What are the potential side effects?
Since DISC-MA is not a drug but likely an app-based therapy or digital intervention, typical medication side effects are not expected; however, specifics aren't provided here.

PAPI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week and post-treatment at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week and post-treatment at 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale

PAPI Trial Design

1Treatment groups
Experimental Treatment
Group I: DISC-MAExperimental Treatment1 Intervention
All participants will be asked to download and use the DISC-MA study application. They will have access to the app throughout the 4 week study.

Find a Location

Who is running the clinical trial?

Woebot HealthLead Sponsor
13 Previous Clinical Trials
1,741 Total Patients Enrolled
Tim Campellone, PhDPrincipal InvestigatorWoebot Health
1 Previous Clinical Trials
162 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being enlisted for this clinical trial?

"Indeed, the information on clinicaltrials.gov indicates that this trial is actively seeking participants. The study was initially posted on March 13, 2024, and last revised on the same date. The research team aims to recruit 200 individuals from a singular site."

Answered by AI

Are there still opportunities for individuals to participate in this ongoing medical research study?

"As per the details on clinicaltrials.gov, patient recruitment is ongoing for this trial. The initial posting of the study was made on March 13th, 2024, with the most recent update also dated as March 13th, 2024."

Answered by AI

Am I eligible to enroll in this clinical trial?

"The trial aims to recruit 200 individuals aged between 18 and 75 experiencing symptoms of depression and anxiety. Notably, potential participants must fulfill the subsequent conditions: Age bracket falls within 18-75 years, Possession or regular use of a smartphone equipped with an up-to-date operating system (Android: OS 8.0+, Apple: iOS 13.0+) along with dependable Wi-Fi access or adequate data plan for interaction with assigned treatment protocol throughout the investigation period, Willingness and availability to actively partake in the program and conclude assessments over a span of four weeks, Proficiency in English reading and writing skills,"

Answered by AI

Are individuals who are 18 years of age or older eligible to participate in this research study?

"In this investigation, individuals between the ages of 18 and 75 are sought. Notably, there are a total of 224 trials catering to those younger than 18 years old and 942 focusing on patients above the age of 65."

Answered by AI
~101 spots leftby Jun 2024